Analyst firms · Morgan Stanley · CVS
Morgan Stanley CVS price target and rating history
CVS Health Corporation (CVS) · Consumer Staples
Morgan Stanley rates CVS Health Corporation (CVS) Overweight with a $119 price target, as of its latest action on Nov 23, 2022. It has published 4 rating actions on CVS since August 2021, including 0 upgrades and 0 downgrades.
- Current rating
- Overweight
- Price target
- $119
- Median target, all firms
- Too few
- Actions on CVS
- 4
Morgan Stanley price target on CVS
Every Morgan Stanley rating on CVS
- Nov 23, 2022
- Dec 13, 2021
- Dec 6, 2021
- Aug 31, 2021
Questions about Morgan Stanley and CVS
- What is Morgan Stanley's price target for CVS?
- Morgan Stanley's latest stated price target for CVS Health Corporation (CVS) is $119, from its action on Nov 23, 2022.
- What is Morgan Stanley's rating on CVS?
- Morgan Stanley rates CVS Overweight, a bullish rating, as of Nov 23, 2022.
- When did Morgan Stanley last change its view on CVS?
- On Nov 23, 2022, Morgan Stanley resumes coverage at Overweight, price target $124 to $119.
More CVS rating histories
All Morgan Stanley ratingsCVS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.